HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DIAGENS-B

450.000

+21.8005.09%

Volume:58.05K

Turnover:25.28M

Market Cap:40.00B

PE:-536.34

High:450.800

Open:410.000

Low:410.000

Close:428.200

52wk High:765.500

52wk Low:178.000

Shares:88.88M

HK Float Shares:88.88M

Volume Ratio:0.39

T/O Rate:0.07%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.839

ROE:-39.50%

ROA:-23.53%

PB:44.19

PE(LYR):-536.34

PS:186.82

Loading ...

Overview Company News Filings

Diagens Biotechnology Sets Book Closure Window Ahead of 23 July 2026 EGM

Bulletin Express

Hangzhou Diagens Biotechnology Announces Extraordinary General Meeting

Hangzhou Diagens Biotech Shareholders Approved 2025 Annual Report at AGM

Hangzhou Diagens Biotechnology announces annual general meeting

Stock Track | DIAGENS-B Soars 22.29% in Morning Session After Securing World-First Medical AI Certification

DIAGENS-B (02526) Surges Over 22% to New High as Core AI Product Secures Landmark Medical Imaging Certification

World's First Medical Imaging AI Secures Top-Level Regulatory Approval: DIAGENS-B's AI AutoVision® Strengthens Technological Moat

Diagens Biotechnology's Chromosome Analysis Device Gets Registration Certificate in China

MT Newswires Live

DIAGENS-B (02526) Secures NMPA Class III Medical Device Registration for AI AutoVision®

Hangzhou Diagens Biotechnology Co Ltd - AI Autovision Receives Class Iii Medical Device Registration Certificate in China

THOMSON REUTERS

Registration Open for "Zhihui Financial 2026 Summer Roadshow Conference"

Stock Track | DIAGENS-B Soars 9.34% Intraday on Stellar 2025 Results and 331.7% Surge in Tech Licensing Revenue

DIAGENS-B Surges Over 9% in Late Trading Following Annual Tech Licensing Revenue Soaring 331.7%, Signaling Commercial Viability of Medical AI Model

Stock Track | DIAGENS-B Soars 15.69% to Record High on Canton Fair Medical Model Debut and Strong Annual Report

DIAGENS-B Shares Surge Over 15% to Record High Following Debut of Proprietary Medical Imaging Model at Canton Fair

Diagens Biotechnology's 2025 Loss Widens

MT Newswires Live

Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine

THOMSON REUTERS

杭州迪安剑生2025年年报聚焦AI医疗影像：营收达1.64424亿元，同比增长133.6%，技术授权收入首超八千万

Bulletin Express

Hangzhou Diagens publishes 2025 annual report

DIAGENS-B Moves to Update Articles of Association After IPO and Regulatory Changes

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/02526/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02526","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02526\",,,,,undefined,":{"symbol":"02526","market":"HK","secType":"STK","nameCN":"DIAGENS-B","latestPrice":450,"timestamp":1789027722238,"preClose":428.2,"halted":0,"volume":58050,"delay":0,"changeRate":0.050910789350770695,"floatShares":88879200,"shares":88879200,"eps":-0.839024,"marketStatus":"Not Yet Opened","change":21.8,"latestTime":"09-10 16:08:42","open":410,"high":450.8,"low":410,"amount":25282430,"amplitude":0.095283,"askPrice":450,"askSize":350,"bidPrice":430,"bidSize":50,"shortable":0,"etf":0,"ttmEps":-1.576,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":0,"adr":0,"listingDate":1774800000000,"exchange":"SEHK","adjPreClose":428.2,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":0.386833403850564,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02526\",,,,,undefined,":{"symbol":"02526","floatShares":88879200,"roa":"-23.53%","roe":"-39.50%","lyrEps":-0.839024,"volumeRatio":0.386833403850564,"shares":88879200,"dividePrice":0,"high":450.8,"amplitude":0.095283,"preClose":428.2,"low":410,"week52Low":178,"pbRate":"44.19","psRate":"186.82","week52High":765.5,"institutionHeld":0,"latestPrice":450,"committee":-0.75,"eps":-0.839024,"divideRate":0,"volume":58050,"delay":0,"ttmEps":-1.576,"open":410,"prevYearClose":99,"prevWeekClose":495.6,"prevMonthClose":529,"prevQuarterClose":309.8,"fiveDayClose":504.5,"twentyDayClose":374,"sixtyDayClose":335},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02526\",params:#limit:5,,,undefined,":[{"date":"2026-08-07","symbol":"02526","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786066200000,"name":null,"time":"","dateTimestamp":1786032000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02526\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02526\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02526\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02526","date":"2026-09-09","current":-285.532995,"percent":0.917431,"low":-545.299386,"twenty":-394.984453,"median":-349.868766,"eighty":-312.635382,"high":-208.205701,"avg":-353.29623,"sd":64.739117,"marketCap":38058073440},"quantilePoints":[{"date":"2026-04-02","current":-272.27881,"twenty":-277.682472,"median":-258.576907,"eighty":-239.167269,"marketCap":20797732800},{"date":"2026-04-10","current":-346.403686,"twenty":-339.232012,"median":-285.787965,"eighty":-250.355764,"marketCap":26663760000},{"date":"2026-04-17","current":-325.713634,"twenty":-334.091876,"median":-317.126763,"eighty":-274.980641,"marketCap":25081710240},{"date":"2026-04-24","current":-330.080861,"twenty":-335.567541,"median":-326.636989,"eighty":-290.709378,"marketCap":25419451200},{"date":"2026-04-30","current":-332.18176,"twenty":-334.015312,"median":-325.713634,"eighty":-310.395031,"marketCap":25597209600},{"date":"2026-05-08","current":-379.447849,"twenty":-346.403686,"median":-328.46508,"eighty":-310.958904,"marketCap":29330136000},{"date":"2026-05-15","current":-344.735778,"twenty":-356.513965,"median":-332.396872,"eighty":-313.054502,"marketCap":26717087520},{"date":"2026-05-22","current":-402.3084,"twenty":-358.871836,"median":-336.827112,"eighty":-315.164028,"marketCap":31107720000},{"date":"2026-05-29","current":-406.641648,"twenty":-379.946058,"median":-343.048303,"eighty":-318.304405,"marketCap":31552116000},{"date":"2026-06-05","current":-360.299962,"twenty":-379.450143,"median":-344.735778,"eighty":-319.954129,"marketCap":27996948000},{"date":"2026-06-12","current":-372.447501,"twenty":-375.674905,"median":-349.027955,"eighty":-324.604965,"marketCap":28921291680},{"date":"2026-06-18","current":-353.616435,"twenty":-376.618141,"median":-353.630358,"eighty":-326.267647,"marketCap":27517000320},{"date":"2026-06-26","current":-343.086832,"twenty":-373.551497,"median":-351.652224,"eighty":-326.764376,"marketCap":26574880800},{"date":"2026-07-03","current":-355.442852,"twenty":-372.637829,"median":-352.781753,"eighty":-328.141924,"marketCap":27552552000},{"date":"2026-07-10","current":-525.783409,"twenty":-380.947063,"median":-353.887402,"eighty":-330.921221,"marketCap":40706673600},{"date":"2026-07-17","current":-330.366333,"twenty":-387.12216,"median":-355.442852,"eighty":-331.092504,"marketCap":25668312960},{"date":"2026-07-24","current":-307.647435,"twenty":-382.392854,"median":-353.630358,"eighty":-326.721913,"marketCap":23908504800},{"date":"2026-07-31","current":-369.618431,"twenty":-381.442978,"median":-353.199094,"eighty":-325.898305,"marketCap":28779084960},{"date":"2026-08-07","current":-476.223264,"twenty":-396.494596,"median":-354.130521,"eighty":-326.679451,"marketCap":37151505600},{"date":"2026-08-14","current":-232.289361,"twenty":-400.612159,"median":-353.887402,"eighty":-323.520825,"marketCap":32885304000},{"date":"2026-08-21","current":-329.499393,"twenty":-396.494596,"median":-352.781753,"eighty":-318.122472,"marketCap":46750459200},{"date":"2026-08-28","current":-306.753265,"twenty":-400.612159,"median":-352.216988,"eighty":-315.707365,"marketCap":43533032160},{"date":"2026-09-04","current":-310.261155,"twenty":-396.494596,"median":-351.396357,"eighty":-315.297789,"marketCap":44048531520},{"date":"2026-09-09","current":-267.65296,"twenty":-394.984453,"median":-349.868766,"eighty":-312.635382,"marketCap":38058073440}],"updateTime":1789070776704},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02526\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1161913779","title":"Diagens Biotechnology Sets Book Closure Window Ahead of 23 July 2026 EGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1161913779","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161913779?lang=en_us&edition=fundamental","pubTime":"2026-07-03 19:25","pubTimestamp":1783077942,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) will convene an extraordinary general meeting (EGM) on Thursday, 23 July 2026. The company will close its register of members from Monday, 20 July...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648166345","title":"Hangzhou Diagens Biotechnology Announces Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2648166345","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648166345?lang=en_us&edition=fundamental","pubTime":"2026-07-03 19:06","pubTimestamp":1783076810,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology announces extraordinary general meetingHangzhou Diagens Biotechnology will hold an extraordinary general meeting in Hong Kong on July 23, 2026.The company plans to publi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nNDL1hjSLr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646356421","title":"Hangzhou Diagens Biotech Shareholders Approved 2025 Annual Report at AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2646356421","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646356421?lang=en_us&edition=fundamental","pubTime":"2026-06-26 18:19","pubTimestamp":1782469169,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotech shareholders approved 2025 annual report at AGMHangzhou Diagens Biotechnology held its 2025 annual general meeting on June 26, 2026.Shareholders adopted the annual report, app","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL4KjnY4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640090163","title":"Hangzhou Diagens Biotechnology announces annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640090163","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640090163?lang=en_us&edition=fundamental","pubTime":"2026-06-04 22:36","pubTimestamp":1780583816,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology will hold its 2025 annual general meeting in Hangzhou on June 26, 2026.Shareholders will vote on the 2025 annual report, profit distribution plan, annual financial report, 2026 budget, auditor reappointment, director pay package, independent director confirmations.Meeting also seeks mandates to issue up to 20% new shares, repurchase up to 10% of H shares, amend the articles of association.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Diagens Biotechnology Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 04, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDLZCQCc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172628570","title":"Stock Track | DIAGENS-B Soars 22.29% in Morning Session After Securing World-First Medical AI Certification","url":"https://stock-news.laohu8.com/highlight/detail?id=1172628570","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172628570?lang=en_us&edition=fundamental","pubTime":"2026-05-26 10:00","pubTimestamp":1779760850,"startTime":"0","endTime":"0","summary":"DIAGENS-B's stock price surged 22.29% during the morning trading session on Tuesday, marking a significant upward movement for the healthcare technology company.The sharp increase followed the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181499976","title":"DIAGENS-B (02526) Surges Over 22% to New High as Core AI Product Secures Landmark Medical Imaging Certification","url":"https://stock-news.laohu8.com/highlight/detail?id=1181499976","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181499976?lang=en_us&edition=fundamental","pubTime":"2026-05-26 09:50","pubTimestamp":1779760249,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) surged more than 22% in morning trading, reaching a high of HK$428 and setting a new record high since its listing. As of the time of writing, the stock was up 17.43% to HK$411,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","ARTY","BK4588","02526","CHAT","02251","AIPO","VXUS","BK1100","BK1189","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104465492","title":"World's First Medical Imaging AI Secures Top-Level Regulatory Approval: DIAGENS-B's AI AutoVision® Strengthens Technological Moat","url":"https://stock-news.laohu8.com/highlight/detail?id=1104465492","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104465492?lang=en_us&edition=fundamental","pubTime":"2026-05-22 20:21","pubTimestamp":1779452465,"startTime":"0","endTime":"0","summary":"On May 22, DIAGENS-B (02526) announced that its self-developed AI AutoVision® Chromosome Karyotype Assisted Diagnostic Software has officially obtained the Class III Medical Device Registration...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHAT","AGIX","BK1100","02526","ARTY","02251","AIPO","BK1189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637319943","title":"Diagens Biotechnology's Chromosome Analysis Device Gets Registration Certificate in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2637319943","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637319943?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:40","pubTimestamp":1779450012,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology's  AI AutoVision core product obtained a Class III Medical Device Registration Certificate from China's National Medical Products Administration.The approved indications under the certificate cover chromosome karyotype analysis for prenatal diagnosis of birth defects using amniotic fluid samples and assisted reproduction using peripheral blood samples, according to a Friday filing with the Hong Kong bourse.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02526","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192558509","title":"DIAGENS-B (02526) Secures NMPA Class III Medical Device Registration for AI AutoVision®","url":"https://stock-news.laohu8.com/highlight/detail?id=1192558509","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192558509?lang=en_us&edition=fundamental","pubTime":"2026-05-22 16:36","pubTimestamp":1779438987,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) announced that on May 20, 2026, its core product AI AutoVision® has obtained a Class III Medical Device Registration Certificate issued by China's National Medical Products...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","BK1583","BK1574","BK1100","AGIX","CHAT","ARTY","AIPO","09996","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637949013","title":"Hangzhou Diagens Biotechnology Co Ltd - AI Autovision Receives Class Iii Medical Device Registration Certificate in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2637949013","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637949013?lang=en_us&edition=fundamental","pubTime":"2026-05-22 16:30","pubTimestamp":1779438653,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nFWN41Z0JW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100532115","title":"Registration Open for \"Zhihui Financial 2026 Summer Roadshow Conference\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1100532115","media":"Stock News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100532115?lang=en_us&edition=fundamental","pubTime":"2026-05-18 10:47","pubTimestamp":1779072449,"startTime":"0","endTime":"0","summary":"In the first half of 2026, the Hong Kong capital market is experiencing a long-awaited period of heightened activity. Since the second quarter, the Hong Kong market has been on a sustained recovery...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02670","BK1198","BK1129","00826","01021","HK0001040143.USD","00305","BK1207","BK1162","02142","LU1813983027.USD","BK1500","BK1144","BK1110","BK4585","06051","LU1719994722.HKD","02411","02675","BK1141","BK1578","02623","BK1190","02655","02685","00290","LU1251922891.USD","SG9999014674.SGD","LU0264606111.USD","BK1109","02729","BK1238","BK1147","02526","LU1023057109.AUD","00363","01907","BK1613","02228","BK1539","LU0572940350.SGD","LU1224709979.USD","BK1258","02650","01396","09696","LU1303224171.USD","LU1770034418.SGD","03858","00400","03317","BK1171","BK1155","BK4588","06636","01300","02706","LU0173614495.USD","BK1169","LU0359201612.USD","BK1161","BK1132","02565","BK1594","BK1163","BK1175","LU0345781412.USD","LU0345780950.USD","LU0469268626.HKD","BK1142","BK1229","LU0588546209.SGD","01333","02726","02652","LU0572939691.SGD","BK1592","LU1328277881.USD","SG9999001093.SGD","VXUS","02659","BK1541","BK1225","LU0630314457.HKD","LU0737861699.HKD","BK1240","BK1583","BK1249","06651","01384","BK1617","LU0359202008.SGD","BK1205","01378","BK1116","BK1117","BK1149","BK1100","BK1574","02575","LU0359201885.HKD","HK0001040168.HKD","LU2039709279.SGD","03881","06090","BK1506","LU0702159699.USD","LU0287142896.SGD","LU0314109678.HKD","06938","08299","LU0307460666.USD","BK1230","BK1191","02889","BK1183","00650","LU1166156734.SGD","06682"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115074411","title":"Stock Track | DIAGENS-B Soars 9.34% Intraday on Stellar 2025 Results and 331.7% Surge in Tech Licensing Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=1115074411","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115074411?lang=en_us&edition=fundamental","pubTime":"2026-05-13 15:29","pubTimestamp":1778657369,"startTime":"0","endTime":"0","summary":"DIAGENS-B's stock price soared 9.34% during the late trading session, following the release of the company's impressive 2025 annual performance report.The surge is attributed to the company's...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181281095","title":"DIAGENS-B Surges Over 9% in Late Trading Following Annual Tech Licensing Revenue Soaring 331.7%, Signaling Commercial Viability of Medical AI Model","url":"https://stock-news.laohu8.com/highlight/detail?id=1181281095","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181281095?lang=en_us&edition=fundamental","pubTime":"2026-05-13 15:28","pubTimestamp":1778657300,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) surged more than 9% in late trading. As of the latest update, the stock rose 9.01% to HK$326.8, with a turnover of HK$40,489,400. The company recently disclosed its 2025...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526","VXUS","150261","BK1100","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197313481","title":"Stock Track | DIAGENS-B Soars 15.69% to Record High on Canton Fair Medical Model Debut and Strong Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1197313481","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197313481?lang=en_us&edition=fundamental","pubTime":"2026-05-04 10:37","pubTimestamp":1777862241,"startTime":"0","endTime":"0","summary":"DIAGENS-B's stock soared 15.69% during the morning session, reaching a record high. The stock has shown significant momentum, with gains continuing from recent positive developments.The surge follows...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147735212","title":"DIAGENS-B Shares Surge Over 15% to Record High Following Debut of Proprietary Medical Imaging Model at Canton Fair","url":"https://stock-news.laohu8.com/highlight/detail?id=1147735212","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147735212?lang=en_us&edition=fundamental","pubTime":"2026-05-04 10:35","pubTimestamp":1777862108,"startTime":"0","endTime":"0","summary":"DIAGENS-B (02526) saw its shares rise more than 15% during the morning session, reaching a record high of HK$335. This represents an increase of nearly 240% compared to its IPO price of HK$99. As of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","02251","02526","IPOS","BK1189","BK1100","VXUS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631010495","title":"Diagens Biotechnology's 2025 Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2631010495","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631010495?lang=en_us&edition=fundamental","pubTime":"2026-04-30 14:13","pubTimestamp":1777529604,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology  booked 67.1 million yuan in attributable loss for 2025, widening from a loss of 43.4 million yuan a year earlier, according to a Hong Kong bourse filing Wednesday.The medical imaging products maker's shares gained nearly 3% in afternoon trade Thursday.Loss per share was 0.84 yuan, compared with 0.55 yuan in 2024.Revenue more than doubled year on year to 164.4 million yuan from 70.4 million yuan.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631050503","title":"Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine","url":"https://stock-news.laohu8.com/highlight/detail?id=2631050503","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631050503?lang=en_us&edition=fundamental","pubTime":"2026-04-30 13:05","pubTimestamp":1777525504,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nTUA6ZPDJC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02526","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118483343","title":"杭州迪安剑生2025年年报聚焦AI医疗影像：营收达1.64424亿元，同比增长133.6%，技术授权收入首超八千万","url":"https://stock-news.laohu8.com/highlight/detail?id=1118483343","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118483343?lang=en_us&edition=fundamental","pubTime":"2026-04-29 23:30","pubTimestamp":1777476643,"startTime":"0","endTime":"0","summary":"杭州迪安剑生生物科技有限公司在本年度报告中披露，2025年度集团整体业务保持快速增长，营业收入达到人民币1.64424亿元（下同，金额均以“亿元”计，下同，数据来自原报告记载的“百万元”除以100换算），较2024年度的0.70352亿元同比增长约133.6%。毛利约为1.18087亿元，较上年同期的0.46061亿元增长超过一倍，毛利率升至71.8%。值得注意的是，技术授权收入约0.84300亿...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"杭州迪安剑生2025年年报聚焦AI医疗影像：营收达1.64424亿元，同比增长133.6%，技术授权收入首超八千万","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631439945","title":"Hangzhou Diagens publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631439945","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631439945?lang=en_us&edition=fundamental","pubTime":"2026-04-29 22:30","pubTimestamp":1777473033,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology annual report for year ended Dec. 31, 2025 flagged a shift from product-led sales toward platform-driven monetization, with technology licensing becoming largest revenue stream at RMB 84.34 million.Core chromosome karyotyping software AI AutoVision was designated a Class III Innovative Medical Device in May 2025, with China NMPA registration still under review and targeted for completion in Q2 2026.iMedImage foundation model scaled to 104 billion parameters, positioning business to expand beyond single-disease tools into broader medical imaging workflows.iMed MaaS platform launched March 31, 2025, with six-month rollout cited at 65 hospital partnerships and 92 imaging-focused models incubated.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fina","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL1TGvcL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","02526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181077977","title":"DIAGENS-B Moves to Update Articles of Association After IPO and Regulatory Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=1181077977","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181077977?lang=en_us&edition=fundamental","pubTime":"2026-04-29 17:06","pubTimestamp":1777453603,"startTime":"0","endTime":"0","summary":"Hangzhou Diagens Biotechnology Co., Ltd. (DIAGENS-B) has announced a plan to revise its Articles of Association following two significant developments: the March 2025 update of the China Securities...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02526"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":96,"code":"91000000","status":"200"}]}}